Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
retsevmo 40 mg capsule
eli lilly (suisse) sa - selpercatinibum - capsule - capsule: selpercatinibum 40 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, e 171, e 172 (nigrum), encre: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula. - ret-fusionspositives nicht-kleinzelliges lungenkarzinom (nsclc), ; ret-fusionspositives schilddrüsenkarzinom,; ret-mutantes medulläres schilddrüsenkarzinom - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
retsevmo 80 mg capsule
eli lilly (suisse) sa - selpercatinibum - capsule - capsule: selpercatinibum 80 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, e 171, e 133, encre: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula. - ret-fusionspositives nicht-kleinzelliges lungenkarzinom (nsclc), ; ret-fusionspositives schilddrüsenkarzinom,; ret-mutantes medulläres schilddrüsenkarzinom - synthetika
Unione Europea -
italiano -
EMA (European Medicines Agency)
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenti antineoplastici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
eutirox
merck serono s.p.a. - levotiroxina sodica - levotiroxina sodica